toxic epidermal necrolysis
Showing 1 - 25 of 2,648
Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)
Recruiting
- Toxic Epidermal Necrolysis
-
Fuzhou, Fujian, ChinaDepartment of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023
Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses Trial in Nashville (Harmonized supportive care, Cyclosporine 5 mg/kg bid
Not yet recruiting
- Stevens-Johnson Syndrome
- Toxic Epidermal Necrolyses
- Harmonized supportive care
- +2 more
-
Nashville, TennesseeVanderblt University Medical Center
Dec 29, 2022
Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease Trial in Boston (Maskin Probe)
Recruiting
- Stevens-Johnson Syndrome
- +5 more
- Maskin Probe
-
Boston, MassachusettsMassachusetts Eye and Ear Hospital
Nov 23, 2021
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum Trial (Medical nutrition)
Completed
- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Medical nutrition
- (no location specified)
Aug 4, 2022
Cytokines With Development of Complications in Burn and Toxic
Recruiting
- Inflammatory Response
- +3 more
- Blood Draw
-
Augusta, GeorgiaJoseph M. Still Burn Center at Doctors Hospital
Aug 24, 2021
Epidermal Necrolysis, Lyell Syndrome, Toxic Epidermal Necrolysis Trial (Adipose derived stromal cells intravenously injected)
Not yet recruiting
- Epidermal Necrolysis
- +5 more
- Adipose derived stromal cells intravenously injected
- (no location specified)
Sep 27, 2021
Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Unknown status
- Stevens-Johnson Syndrome
- +2 more
- Site specific standard of care comparison
- (no location specified)
Dec 1, 2020
Toxic Epidermal Necrolysis Trial in Sacramento (Clobetasol 0.05% ointment, Placebo)
Withdrawn
- Toxic Epidermal Necrolysis
- Clobetasol 0.05% ointment
- Placebo
-
Sacramento, CaliforniaUniversity of California, Davis Department of Dermatology
Aug 7, 2019
Rare Diseases, Toxic Epidermal Necrolyses Trial in LYON cedex 03, Lyon (Filgrastim, Placebo)
Recruiting
- Rare Diseases
- Toxic Epidermal Necrolyses
- Filgrastim
- Placebo
-
LYON cedex 03, France
- +1 more
Mar 15, 2022
Sterile Corneal Melt Trial in Montreal (Topical Infliximab)
Recruiting
- Sterile Corneal Melt
- Topical Infliximab
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Dec 12, 2022
Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Athens, GreeceLocal Institution - 0001
Oct 26, 2022
/Effectiveness of Nivolumab in Routine Oncology Practice
Active, not recruiting
- Melanoma
- Lung Cancer
-
Princeton, New JerseyInventiv
Feb 24, 2022
Measurement of Serum microRNA in Acne Vulgaris Patient
Not yet recruiting
- Acne Vulgaris
- measure serum MicroRNA in acne vulgaris
- (no location specified)
May 23, 2023
Cicatrizing Conjunctivitis, Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum, Sjogren Syndrome Trial in Taipei
Unknown status
- Cicatrizing Conjunctivitis
- +5 more
- minor salivary gland transplantation
-
Taipei, TaiwanDepartment of Ophthalmology, National Taiwan University Hospital
Feb 10, 2019
Human Leukocyte Antigen Class II Alleles and Haplotypes
Recruiting
- Pemphigus
- +3 more
- A single blood sample for HLA typing
-
Moscow, Russian FederationSechenov University
Mar 10, 2022
Steven-Johnson Syndrome, Toxic Epidermal Necrolysis, Drug Reaction With Eosinophilia and Systemic Symptoms Trial in Bangkok
Unknown status
- Steven-Johnson Syndrome
- +4 more
-
Bangkok, ThailandFaculty of Medicine, Chulalongkorn University
Feb 15, 2019
Pre-Eclampsia, Gestational Hypertension, Superimposed Pre-Eclampsia Trial in Austin, Galveston (Hydrochlorothiazide 50mg Tablet,
Recruiting
- Pre-Eclampsia
- +5 more
- Hydrochlorothiazide 50mg Tablet
- Placebo Tablet
-
Austin, Texas
- +1 more
Feb 10, 2022
Genetic and Clinical Factors for Serious Skin Reactions Among
Terminated
- SCAR
- Blood or Saliva
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Perlman School of Medicine
Jan 19, 2021
Operative Time, Wound Heal Trial in Galveston (INSORB: subcuticular stapling device, Subcuticular monocryl suture manufactured
Recruiting
- Operative Time
- Wound Heal
- INSORB: subcuticular stapling device
- Subcuticular monocryl suture manufactured by Ethicon
-
Galveston, TexasJohn Sealy Hospital at University of Texas Medical Branch
Nov 16, 2021
Gout Trial (HKIIM-KU formula, Placebo)
Not yet recruiting
- Gout
- HKIIM-KU formula
- Placebo
- (no location specified)
Aug 10, 2022
Osteoarthritis, Tendinitis, Sports Injury Trial in Encino (Umbilical Allograft)
Not yet recruiting
- Osteoarthritis
- +7 more
- Umbilical Allograft
-
Encino, CaliforniaAdvanced Stem Cell Institute
Sep 10, 2021
Bacterial Vaginoses Trial in Galveston (Metronidazole Oral, Placebo Oral Tablet)
Recruiting
- Bacterial Vaginoses
- Metronidazole Oral
- Placebo Oral Tablet
-
Galveston, TexasUniversity of Texas Medical Branch
Jul 29, 2021
Autologous Epidermal Cell Transplantation Trial (Cultured autologous epidermal cell membrane)
Not yet recruiting
- Autologous Epidermal Cell Transplantation
- Cultured autologous epidermal cell membrane
- (no location specified)
May 31, 2023
Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
Recruiting
- Stevens-Johnson Syndrome
- +7 more
-
Créteil, FranceHenri Mondor
May 2, 2022